In an Expert View piece, industry analyst Allied Market Research considers the potential and progress of a growing stream of applied clinical immunology.
The world faces tremendous disease burden through growth in epidemics such as HIV-AIDS and hepatitis. Recently, the Zika disease has been circumambulating the globe. Most of these diseases have similar symptoms but if undiagnosed can lead to devastating consequences.
These infectious and chronic diseases can be efficiently combated through a thorough diagnosis and different immunodiagnostic tests and analyses. Immunodiagnostics plays a vital role in understanding disease in the human body. The proteins expressed in the sera of a diseased person are different than those in a healthy person. These proteins therefore act as markers to determine the diseased state.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze